Artificial intelligence (AI) is changing the world. Corporations are racing to establish themselves as leaders in the field, while investors want to cash in by putting their hard-earned money into the most promising AI companies. However, prominent names in this fast-growing space have seen their shares soar in the past two years, and the valuations of some have become quite expensive.
Two AI healthcare stocks — Recursion Pharmaceuticals (NASDAQ: RXRX) and Teladoc Health (NYSE:…
Article Source
https://finance.yahoo.com/news/investors-buy-2-beaten-down-133000655.html
